Is Sabra Healthcare REIT Inc (SBRA) overvalued? · P/E 29, rev $774.6M
Sabra Healthcare REIT Inc (SBRA) is a reit - healthcare facilities company listed on NASDAQ.
This page asks whether Sabra Healthcare REIT Inc (SBRA) looks expensive on cached numbers — not a short thesis.
Latest reported SBRA revenue for 2025-12-31 was $774.6M. Net income was $155.6M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. SBRA currently screens at market cap $4.55B and trailing P/E 28.7.
SBRA currently screens at market cap $4.55B and trailing P/E 28.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SBRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SBRA stock page for the full model, not this heading.
Not investment advice.